APTOF · Aptose Biosciences Inc.
Substantial doubt about the company's ability to continue as a going concern.
“The aforementioned conditions raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed May 13, 2026
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on Feb 26, 2025; bars on opposite sides are not compared.
The closing range uses available history since Jul 2, 2026; less than a full year is stored.
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
APTOF
this stock
Aptose Biosciences Inc.
|
$4.31M | — | — | — | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$127.55B | +11.0% | +46.2% | 29.3 | 1.9% |
|
MRNA
Moderna, Inc.
|
$78.65B | +568.0% | +4.3% | — | 8.2% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$76.14B | -4.2% | +20.8% | 18.3 | 2.5% |
|
CSLLY
Csl Ltd
|
$60.24B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- % held
- 0.9%
- Net QoQ
- +200 sh
- Top holder
- DRW Securities, LLC
Performance
Raw-price comparisons begin at the captured split on Feb 26, 2025; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| APTOF | — | — | — | — | — |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | — | — | — | — | — |